Validation of a Five-Year Prognostic Model Using (123)I-metaiodobenzylguanidine Scintigraphy in Patients with Heart Failure.

Ishibashi Y, Kasama S, Kurabayashi M, Ishii H

Open source

DOI
10.17996/anc.23-00177
Published
2023
Container
Annals of nuclear cardiology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.17996/anc.23-00177,
  title = {Validation of a Five-Year Prognostic Model Using (123)I-metaiodobenzylguanidine Scintigraphy in Patients with Heart Failure.},
  author = {Ishibashi Y and Kasama S and Kurabayashi M and Ishii H},
  year = {2023},
  journal = {Annals of nuclear cardiology},
  doi = {10.17996/anc.23-00177},
  url = {https://doi.org/10.17996/anc.23-00177}
}

RIS

TY  - JOUR
TI  - Validation of a Five-Year Prognostic Model Using (123)I-metaiodobenzylguanidine Scintigraphy in Patients with Heart Failure.
AU  - Ishibashi Y
AU  - Kasama S
AU  - Kurabayashi M
AU  - Ishii H
PY  - 2023
JO  - Annals of nuclear cardiology
DO  - 10.17996/anc.23-00177
UR  - https://doi.org/10.17996/anc.23-00177
ER  - 

APA

Y, I., S, K., M, K., & H, I. (2023). Validation of a Five-Year Prognostic Model Using (123)I-metaiodobenzylguanidine Scintigraphy in Patients with Heart Failure.. Annals of nuclear cardiology. https://doi.org/10.17996/anc.23-00177

Source records